California has enacted two bills that will significantly impact private equity firms, management services organizations (MSOs), and physician practices operating in the state.

Assembly Bill 1415 (AB 1415) and Senate Bill 351 (SB 351) build on longstanding concerns about the corporate practice of medicine (CPOM) by expanding regulatory oversight of transactions and strengthening statutory prohibitions